Glycolysis: The Bridge Between Cellular Interaction and Alzheimer’s Disease
Biomolecules · 28.05.2026 · 16 (6) · 796
DOI: 10.3390/biom16060796 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 28.05.2026. Verfasst von Qian Lei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Hospital of China Medical University, NO. 155, North Nanjing Street, Heping District, Shenyang 110001, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Glycolysis, Cell Communication. Die Arbeit nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Red Cross Foundation, The Health Commission of Liaoning Province.
Themen: Demenz
Abstract (Originalsprache)
The pathological progression of Alzheimer’s disease (AD) involves not only intrinsic neuronal lesions but is also closely associated with dysregulation of intercellular communication within the neuroimmune microenvironment. Glycolysis, as a central pathway in cellular energy metabolism, exhibits significant abnormalities in AD, and changes in its activity may further influence disease progression by modulating interactions between neurons. This article aims to systematically elucidate how glycolysis, as a key component of metabolic regulation, participates in the regulation of cellular interactions during the progression of AD, and to explore its potential mechanisms and therapeutic implications. Firstly, it systematically reviews the key changes in interactions between cells in AD, including microglia, astrocytes, oligodendrocytes, and neurons, and their roles in neuroinflammation, synaptic loss, and amyloid deposition. Secondly, by analysing alterations in the glycolytic metabolic profiles of various neuronal cell types in AD, we explore in depth how glycolysis regulates cellular signalling, inflammatory responses, and cellular function, thereby influencing cell–cell interactions. Lastly, by combining current research on the control of the glycolytic pathway in AD with possible therapeutic methods, we propose a novel way to stop the progression of the disease by focusing on cell interactions through mediating glycolysis. By tracing the causal chain in AD through which glycolysis acts as a bridge via altered cell–cell interactions, this paper aims to provide a theoretical basis for the development of disease-modifying therapies based on metabolic reprogramming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Hospital of China Medical University, NO. 155, North Nanjing Street, Heping District, Shenyang 110001, China.
ORCID-Profile: Bo Fang
Förderung
- National Natural Science Foundation of China
- Liaoning Red Cross Foundation
- The Health Commission of Liaoning Province
- Natural Science Foundation of China
- LiaoNing Revitalization Talents Program
- Liaoning Province Red Cross Foundation’s Research Support for Public Welfare Project
Zitieren
APA
Lei, Q., He, Y., & Fang, B. (2026). Glycolysis: The Bridge Between Cellular Interaction and Alzheimer’s Disease. Biomolecules, 16(6), 796. https://doi.org/10.3390/biom16060796
Vancouver
Lei Q, He Y, Fang B. Glycolysis: The Bridge Between Cellular Interaction and Alzheimer’s Disease. Biomolecules. 2026;16(6):796. doi:10.3390/biom16060796
BibTeX
@article{Lei2026,
author = {Lei, Qian and He, Yinghan and Fang, Bo},
title = {Glycolysis: The Bridge Between Cellular Interaction and Alzheimer’s Disease},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {796},
doi = {10.3390/biom16060796}
}
EUVIMED